eNauka - pregled

Pregled prema Autor Shan, K

Prikaz rezultata 1 do 2 od 2
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2026Early symptomatic improvement with obefazimod in patients with moderately to severely active ulcerative colitis: pooled results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trialsArmuzzi, A; Atreya, R; Sparrow, MP; Markovic, S; Le, Berre C; Hlavaty, T; Treton, X; Cataldi, F; Jacobstein, D; Rabbat, C;
Shan, K; Dubinsky, MC;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2026Impact of age of subjects on the efficacy and safety of once-daily oral obefazimod in moderately to severely active ulcerative colitis: week 8 results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trialsMagro, F; Tilg, H; Cataldi, F; Jacobstein, D; Rabbat, C; Shan, K; Nancey, S; Markovic, S; Rocco, R; Harlacher, L;
Yarur, A;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.